Insys Therapeutics, Inc.
Insys Therapeutics, Inc. (INSY) is a publicly traded company in the Unknown sector. Across all available filings, 20 corporate insiders have executed 241 transactions totaling $59.3M, demonstrating a bearish sentiment with -$50.3M in net insider flow. The most recent transaction on Apr 17, 2019 involved a transaction of 12,475 shares valued at $0.
INSY Insider Activity Summary
Who Is Buying INSY Stock?
No significant insider buying has been recorded for INSY in the recent period.
Who Is Selling INSY Stock?
No significant insider selling has been recorded for INSY in the recent period.
Is Insys Therapeutics, Inc. Insider Trading Bullish or Bearish?
Based on recent SEC filings, insider sentiment for INSY is bearish with an Insider Alignment Score of 8/100 and a net flow of -$50.3M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
INSY Frequently Asked Questions
Understanding INSY Insider Activity
Insider trading at Insys Therapeutics, Inc. (INSY) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 20 insiders are actively trading INSY stock, having executed 241 transactions in the past 90 days. The most active insider is N. Kapoor Trust Dated September 20 1989 John (Executive), who has made 12 transactions totaling $57.9M.
Related Tools
Track Insys Therapeutics, Inc. Insider Activity
Get notified when executives and directors at INSY file new Form 4 transactions